Group 1 - The core point of the announcement is that Jiujiang Defu Technology Co., Ltd. plans to acquire at least 51% of Anhui Huiru Technology Co., Ltd. through cash purchase and capital increase, making Huiru Technology a subsidiary of Defu Technology [2][3] - The acquisition is based on a signed Letter of Intent, and specific transaction details will be determined after due diligence and negotiations [2][3][4] - The transaction does not constitute a related party transaction and is not expected to be classified as a major asset restructuring under relevant regulations [3][4] Group 2 - Anhui Huiru Technology Co., Ltd. has a registered capital of 224.38 million yuan and specializes in the research, production, and sales of high-performance electrolytic copper foil, with a current production capacity of 20,000 tons per year [5][6][17] - The actual controller of Huiru Technology is Wang Sungeng, who holds 44.62% of the company's shares directly and indirectly [7] - The acquisition aims to enhance Defu Technology's production capacity and market position in response to growing demand in the industry [17]

Group 1 - The core viewpoint of the article is that Yanjiang Co., Ltd. (300658) is planning a significant asset restructuring by acquiring control of Ningbo Yongqiang Technology Co., Ltd. through a combination of issuing shares and cash payments, along with raising supporting funds [1][4]. Group 2 - Yanjiang Co., Ltd. announced a suspension of its stock trading starting January 5, 2026, due to the planned major asset restructuring [1]. - Ningbo Yongqiang Technology Co., Ltd., established in December 2019, specializes in the R&D, manufacturing, and sales of electronic specialty materials and automotive parts, with high-end products certified by major companies like Intel and Huawei [4]. - Since its inception, Yongqiang Technology has secured a total of 210 million yuan in market investments from various industry capital and well-known funds, with a valuation exceeding 1 billion yuan [4]. Group 3 - Yanjiang Co., Ltd. was founded in 2000 and primarily engages in the R&D, production, and sales of surface materials for disposable hygiene products, with key products including 3D perforated non-woven fabric and PE perforated film [6]. - In the first three quarters of 2025, Yanjiang Co., Ltd. achieved a revenue of 1.295 billion yuan, representing a year-on-year growth of 22.99%, and a net profit attributable to shareholders of 42.5 million yuan, up 27.95% year-on-year [6]. - On December 31, 2025, the stock price of Yanjiang Co., Ltd. surged, with an intraday increase of over 12%, closing with an 11.68% rise [6].

延江股份（300658）将停牌。 1月4日晚间，延江股份（300658）发布《关于筹划重大资产重组的停牌公告》。公告显示，公司正在筹划发行股份等方式购买资产事项， 同时拟募集配套资金，预计本次交易可能构成重大资产重组。公司股票自2026年1月5日开市时起开始停牌。 公开资料显示，延江股份成立于2000年，主要从事一次性卫生用品面层材料的研发、生产和销售，公司的主要产品为3D打孔无纺布和PE打 孔膜等，主要是用作妇女卫生用品、婴儿纸尿布等一次性卫生用品的面层材料。2025年前三季度，公司实现营业收入12.95亿元，同比增长 22.99%；实现归母净利润4250.18万元，同比增长27.95%。 值得注意的是，2025年12月31日，延江股份股价大涨，盘中一度涨超12%，收盘仍有11.68%的涨幅。 据悉，延江股份本次交易的标的公司为宁波甬强科技有限公司，该公司经营范围包括电子专用材料研发；电子专用材料制造；电子专用材料 销售；汽车零部件研发；汽车零部件及配件制造；汽车零配件零售；计算机软硬件及辅助设备零售；软件开发等。 宁波甬强科技有限公司官网显示，该公司成立于2019年12月，主要研发生产IC载板、高端显示基 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 延江股份（300658）将停牌。 1月4日晚间，延江股份（300658）发布《关于筹划重大资产重组的停牌公告》。公告显示，公司正在筹 划发行股份等方式购买资产事项，同时拟募集配套资金，预计本次交易可能构成重大资产重组。公司股 票自2026年1月5日开市时起开始停牌。 公开资料显示，延江股份成立于2000年，主要从事一次性卫生用品面层材料的研发、生产和销售，公司 的主要产品为3D打孔无纺布和PE打孔膜等，主要是用作妇女卫生用品、婴儿纸尿布等一次性卫生用品 的面层材料。2025年前三季度，公司实现营业收入12.95亿元，同比增长22.99%；实现归母净利润 4250.18万元，同比增长27.95%。 据悉，延江股份本次交易的标的公司为宁波甬强科技有限公司，该公司经营范围包括电子专用材料研 发；电子专用材料制造；电子专用材料销售；汽车零部件研发；汽车零部件及配件制造；汽车零配件零 售；计算机软硬件及辅助设备零售；软件开发等。 宁波甬强科技有限公司官网显示，该公司成立于2019年12月，主要研发生产IC载板、高端显示基板、高 速高频载板等，高端 ...

Group 1: Company Overview - 蘅东光, established in September 2011, specializes in the R&D, manufacturing, and sales of passive optical devices in the optical communication field [1] - 新广益, founded in 2004, focuses on the R&D, production, and sales of high-performance specialty functional materials, including anti-overflow special films and strong resistance special films [6][7] Group 2: Financial Performance - 蘅东光's IPO price is set at 31.59 CNY per share, with a market capitalization of 4.5 billion CNY [2] - 新广益's IPO price is 21.93 CNY per share, with a market capitalization of 3.22 billion CNY [7] - 蘅东光's revenue and net profit are projected to grow significantly, with a compound annual growth rate (CAGR) of 66.33% for revenue and 61.34% for total assets from 2022 to 2024 [6] - 新广益's main business revenue for 2022 to mid-2025 is projected to be 4.55 billion CNY, 5.16 billion CNY, 6.57 billion CNY, and 3.13 billion CNY, with net profits of 815.13 million CNY, 832.83 million CNY, 1.16 billion CNY, and 592.06 million CNY respectively [9] Group 3: Market Position and Competitive Landscape - 蘅东光 has undertaken significant research projects, including 400G ultra-high-density passive multi-core optical connection components and systems [1] - 新广益 has broken the technological monopoly of foreign companies in the production of anti-overflow special films and strong resistance special films, becoming the market leader in China for these products [7][8] Group 4: Investment and Development Plans - 蘅东光 plans to invest 2.10 billion CNY in the expansion of its Guilin manufacturing base, 1.00 billion CNY in the expansion of its Vietnam production base, and 1.14 billion CNY in the construction of its optical R&D center [2] - 新广益 intends to allocate 6.38 billion CNY entirely to functional material projects [7] Group 5: Client Relationships and Product Applications - 蘅东光's products are primarily exported, with major clients including AFL, Coherent, Jabil, and others, serving large global brands like AT&T, Verizon, Google, and Amazon [5] - 新广益's main clients include well-known companies such as Pengding Holdings, Weixin Electronics, and GoerTek, with a focus on expanding its customer base [8]

本报讯(记者袁传玺)天眼查App显示，近日，江海电容创新研发(浙江)有限公司成立，注册资本5000万 元，经营范围包括电子专用材料研发、以自有资金从事投资活动。股东信息显示，该公司由江海股份 （002484）、浙江省交通集团技术研究总院有限责任公司、浙江省经济建设投资有限公司共同持股。 ...

人民财讯12月26日电，企查查APP显示，近日，江海电容创新研发(浙江)有限公司成立，注册资本5000 万元，经营范围包含：电子专用材料研发；以自有资金从事投资活动。企查查股权穿透显示，该公司由 浙江省经济建设投资有限公司、江海股份（002484）等共同持股。 ...

| 打新早知道 | | | | | --- | --- | --- | --- | | 南财快讯 | | | | | 今日申购 | | | | | 301687.SZ 新广益 | | | | | 发行价(元/股) | 机构报价(元/股) | 市值(亿元) | 所属行业 | | 电子专用材料制 | 21.93 | 22.22 | 24.16 | | 造 | | | | | 发行市盈率 | 行业市盈率 | 可比公司 | 可比公司动态市盈率 | | 方邦股份 | 亏损 | 57.92 | 28.59 | | 斯迪克 | 274.14 | | | | 业绩情况 | | | | | 7.0 - | - 50% | | | | 6.0 | 40% | | | | 5.0 | 30% | | | | 4.0 | 20% | | | | 3.0 | 10% | | | | 2.0 | 0% | | | | -10% | 1.0 | | | | 0.0 | -20% | AAAAH | AAAAH | 12月22日，可申购创业板的新广益（301687.SZ）与沪市主板的陕西旅游（603402.SH）。 新广益是一家专注于高性能 ...

Core Viewpoint - The news highlights the approval of three companies for listing and refinancing, indicating a positive trend in the capital market with successful IPOs and refinancing activities [1][31]. Group 1: Company Approvals - Three companies were approved in the meetings held on December 18, 2025, including one IPO and two refinancing cases [1][31]. - Wuxi Chuangda New Materials Co., Ltd. received approval for its IPO, focusing on high-performance thermosetting composite materials [34][36]. - Doctor Glasses Chain Co., Ltd. was approved for refinancing, aiming to enhance its retail operations in the eyewear sector [41][42]. Group 2: Financial Data - Wuxi Chuangda reported total assets of approximately 644.27 million yuan as of June 30, 2025, with total equity of about 564.70 million yuan [36]. - The company achieved operating revenues of 211.47 million yuan in the first half of 2025, with a net profit of approximately 33.32 million yuan [37]. - Doctor Glasses reported operating revenues of 9.62 billion yuan, 11.76 billion yuan, and 12.03 billion yuan for the years 2022 to 2024, with corresponding net profits of 75.81 million yuan, 128 million yuan, and 104 million yuan [45]. Group 3: Fundraising Plans - Wuxi Chuangda plans to raise 300 million yuan for three major projects, including a semiconductor packaging materials production line and a research and development center [38]. - Doctor Glasses aims to raise 375 million yuan for four projects, including the construction and upgrade of retail stores and digital platform enhancements [48]. Group 4: Shareholding Structure - Wuxi Chuangda's major shareholders include Zhang Jun and Lu Nanping, with Zhang controlling approximately 26.98% of the voting rights [35][36]. - Doctor Glasses' major shareholders are Alexander Liu and Louisa Fan, holding a combined 40.44% of the company's shares [43].

聚和材料回复称，目前韩国收购事宜一切按计划进行，国内相关产能的建设规划正在逐步开展中，待收 购完成后公司会及时履行信息披露义务，敬请您关注公司后续披露的公告。 格隆汇12月17日｜有投资者在互动平台向聚和材料提问：请问公司在韩国的收购项目，12月3日工商登 记成功了吗，后续还有哪些关键审批环节方能落地，项目后续规划如何？ ...